Eli Lilly and Company

Magnus Wilhelm Walter

John Joseph Masters

Manuel Javier Cases-Thomas

Peter Thaddeus Gallagher

Barry P Clark

Hélène Catherine Eugénie Rudyk

Maria Ann Whatton

Jeremy Gilmore

Carlos Lamas-Peteira

Christopher David Beadle

Virginia Ann Wood

Helen Louise Haughton

Graham Henry Timms

Sandra Ann Filla

Robin G Simmonds

Nicolas Jacques Francois Dreyfus

Anette Margareta Johansson

Eric George Tromiczak

Simon James Richards

Selma Sapmaz

Jikesh Arvind Shah

Gordon Iain Campbell

Teresa Man

Sivi Ouwerkerk-Mahadevan

Thierry J Masquelin

Helene Catherine Rudyk

The invention provides certain 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds, particularly compounds of formula I and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat Parkinsons disease Formula (I). 

3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds

A serotonin and norepinephrine reuptake inhibitor of the formula: its uses, and methods for its preparation are described.

Serotonin and norepinephrine reuptake inhibitor

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).

3-Aminopyrrolidines as inhibitors of monoamine uptake

3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake

Compounds of the general formula (I) are inhibitors of the reuptake of norepinephrine. As such, they may be useful for the treatment of disorders of the central and/or peripheral nervous system. 

Morpholine derivatives as norepinephrine reuptake inhibitors

2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors

Aryl and heteroaryl morpholine derivatives

Growing community of inventors

Basingstoke, United Kingdom

Magnus Wilhelm Walter